Skip to main content
OXFORD NANOPORE TECHNOLOGIES PLC logo

OXFORD NANOPORE TECHNOLOGIES PLC — Investor Relations & Filings

Ticker · ONT ISIN · GB00BP6S8Z30 LEI · 213800IRWQ2Q6M2CDW55 IL Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2023-06-12 Regulatory Filings
Country GB United Kingdom
Listing IL ONT

About OXFORD NANOPORE TECHNOLOGIES PLC

https://nanoporetech.com/

Oxford Nanopore Technologies PLC develops and commercializes a proprietary technology platform for DNA and RNA sequencing. The company's core technology is based on nanopore sensing, which enables the direct, real-time analysis of single molecules. This electronic method facilitates the sequencing of native nucleic acids, generating long-read data without requiring amplification. The platform is uniquely scalable, offering a range of products from portable, pocket-sized devices like the MinION to high-throughput instruments for population-scale projects. This technology provides researchers with immediate access to data, enabling rapid insights across various fields of biological research, including human genetics, cancer research, microbiology, and environmental science.

Recent filings

Filing Released Lang Actions
National German rare disease study
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 3263C' and is distributed via 'RNS, the news service of the London Stock Exchange'. It announces a research collaboration agreement ('National German rare disease study') and includes commentary from the CEO and other stakeholders. This format—a brief announcement of a specific corporate event or development released through an official regulatory news service—is characteristic of a general regulatory filing that doesn't fit a more specific category like 10-K, ER, or DIV. Since it is a specific announcement released via RNS, and it is not a short announcement merely pointing to another document (which would be RPA), the most appropriate classification is the general regulatory filing category.
2023-06-12 English
Change of Broker
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and concludes with information about RNS, the news service of the London Stock Exchange. The content announces a 'Change of Broker' (appointment of J.P. Morgan Securities plc as joint corporate broker). This type of announcement, which is a general regulatory update distributed via the RNS system and does not fit into specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), is best classified under the general regulatory announcement category. Given the explicit reference to RNS and the nature of the announcement (a corporate action update distributed through the regulatory news service), the most appropriate code is RNS (Regulatory Filings), which serves as the fallback for miscellaneous regulatory announcements.
2023-06-09 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement released via RNS (RNS Number: 3864B) from Oxford Nanopore Technologies plc, dated June 1, 2023. The core content announces the 'Issue of Equity' (231,275 ordinary shares issued following option exercises and remuneration schemes) and provides the 'Total Voting Rights' as of May 31, 2023, referencing FCA Disclosure Guidance and Transparency Rule 5.6.1. This content directly relates to changes in the number of shares outstanding and voting rights, which falls under the 'Share Issue/Capital Change' category (SHA). Although it is distributed via RNS, the specific subject matter is a capital change, making SHA the most precise classification over the general RNS fallback.
2023-06-01 English
London Calling Technology Update
Regulatory Filings Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number : 9633Z) from Oxford Nanopore Technologies plc, dated May 19, 2023. It details technology updates presented at their 'London Calling' conference, including performance metrics, new product rollouts (PromethION 2 Solo, new MinION), and the launch of direct RNA sequencing. Crucially, it concludes by announcing an 'Analyst and Investor Call' scheduled for May 22, 2023, to discuss these updates and provides links to the presentation replay and the webcast. This structure—a detailed update followed by an announcement of a follow-up investor call—is characteristic of a broad regulatory disclosure that doesn't fit the specific definitions of an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). Since it is a formal, non-standard announcement distributed via the RNS system, and it is not merely announcing the publication of a major report (which would suggest RPA), the most appropriate general category for a significant, non-standard regulatory disclosure is Regulatory Filings (RNS).
2023-05-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 2887Z' and the footer stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content is a 'TR-1: Standard form for notification of major holdings' filed by Baillie Gifford & Co regarding an acquisition of voting rights in Oxford Nanopore Technologies plc, crossing the 5% threshold on 11-May-2023. This type of mandatory disclosure regarding changes in significant share ownership directly maps to the Major Shareholding Notification category.
2023-05-12 English
Next step of PathoQuest strategic collaboration
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated May 12, 2023. It announces a strategic collaboration between Oxford Nanopore Technologies plc and PathoQuest SAS regarding a new sequencing-based quality control test for biopharma. The text structure, the presence of 'RNS Number', the 'ENDS' marker, and the concluding section mentioning 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange' strongly indicate this is a general regulatory announcement or press release distributed via the RNS system. Since it is an announcement of a business development/collaboration rather than a specific financial report (like 10-K, ER, IR) or a specific corporate action (like DIV, SHA), the most appropriate classification is the general regulatory announcement category.
2023-05-12 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.